| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.0061 | 1 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.0043 | 1 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.0038 | 1 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |